Background illustration for clinical trials search

Paid Clinical Trials Raleigh

Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

for
Sinonasal Squamous Cell Carcinoma,
Location: Chapel Hill NC, Charlottesville VA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07281417

Phase 2, Recruiting

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

for
Breast Cancer, Metastatic Breast Cancer,
Location: Chapel Hill NC, Baltimore MD, Philadelphia PA,
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07340541

Phase 2, Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

for
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy),
Location: Fayetteville NC, New York NY, Cordova TN,
Sponsor: Grifols Therapeutics LLC

Sex: All

Age: 18+

Code: NCT07540221

Phase 3, Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia
Location: Chapel Hill NC, Greenville NC, Winston-Salem NC,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase 3, Recruiting

Multimedia Aid for Genetic Testing in Gynecologic Oncology

for
Ovary Cancer, Endometrial Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: Female

Age: 18+

Code: NCT07084168

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for
Angioimmunoblastic T-cell Lymphoma,
Location: Chapel Hill NC, Winston-Salem NC, Charlottesville VA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase 2, Recruiting

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Chapel Hill NC, Richmond VA, Pittsburgh PA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06295731

Phase 2, Phase 3, Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Chapel Hill NC, South Hill VA, Midlothian VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase 2, Recruiting

Brain Slice Explants to Predict Drug Response in Brain Tumors

for
Central Nervous System Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 0+

Code: NCT05978557

Recruiting

Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

for
GastroEsophageal Cancer
Location: Chapel Hill NC, Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06497569

Recruiting

Digoxin Medulloblastoma Study

for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: Chapel Hill NC, Charlotte NC, Washington D.C. DC,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1 - 30

Code: NCT06701812

Phase 2, Recruiting

ETHAN - ET for Male BC

for
Male Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Chapel Hill NC, Washington D.C. DC, Pittsburgh PA,
Sponsor: Jose Pablo Leone

Sex: Male

Age: 18+

Code: NCT05501704

Phase 2, Recruiting

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

for
Oropharyngeal Cancer
Location: Chapel Hill NC, Atlanta GA, Cleveland OH, Detroit MI,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05451004

Phase 3, Recruiting

Study of Trilaciclib and Lurbinectidin

for
Lung Cancer, Small-cell Lung Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05578326

Phase 2, Recruiting

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

for
Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus
Location: Smithfield NC, Charlotte NC, Indianapolis IN, DeBary FL,
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07355218

Phase 3, Recruiting

UNC Metastatic Cancer Radiation Therapy Registry

for
Cancer, Metastatic Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06306924

Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Chapel Hill NC, Winston-Salem NC, Norfolk VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase 2, Recruiting

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

for
Solid Tumor Malignancies, Metastatic Cancer, Breast Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06896162

Recruiting

Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)

for
Relapsed or Refractory Large B-cell Lymphoma
Location: Chapel Hill NC, Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06788964

Phase 2, Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for
Acute Myeloid Leukemia,
Location: Chapel Hill NC, Winston-Salem NC, Charlotte NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase 1, Recruiting